Pyrimidine compounds and methods for making and using the same

Details Pyrimidine compounds and methods for making and using the same Pyrimidine compounds and methods for making and using the same

2001-02-01

2002-07-23

Shah, Mukund J. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S319000, C544S320000, C544S321000, C435S192000

Reexamination Certificate

active

06423720

ABSTRACT:

FIELD OF THE INVENTION
This invention relates to pyrimidine compounds and pharmaceutically acceptable salts, solvates and prodrugs thereof. The present compounds have been found useful in resisting and treating infections in immunocompromised patients. These compounds are also useful as antitumor, antibiotic, antimalarial, antifungal, antiprotozoal, antituberculosis and anti
Mycobacterium avium
agents, and can also be used as synergistic agents when used with sulfonamides. Methods of preparing and using these compounds are also provided.
BACKGROUND OF THE INVENTION
Various pyrimidine systems, such as the pyrido pyrimidines, pyrrolo pyrimidines and furo pyrimidines, have been studied due to their involvement in the inhibition of dihydrofolate reductase (DHFR) enzyme activity. Because DHFR reduces dihydrofolate to tetrahydrofolate, inhibition of DHFR deprives the cell of. tetrahydrofolate, without which the cell cannot produce 5,10-methylenetetrahydrofolate. 5,10-Methylene-tetrahydrofolate is essential for cell growth. The inhibition of DHFR by the compounds of this invention results in the inhibition of DNA synthesis and leads to cell death.
The pyrimidine derivatives disclosed herein also function as thymidylate synthase (TS) inhibitors. TS, along with DHFR, forms part of the system responsible for the synthesis of deoxythymidylate (dTMP) from deoxyuridylate (dUMP). TS catalyzes the sole de novo synthesis of dTMP from dUMP. Inhibition of TS, therefore, deprives the cell of thymidine, which is an essential constituent of DNA.
SUMMARY OF THE INVENTION
The present invention provides pyrimidine compounds, and pharmaceutically acceptable salts, solvates and prodrugs thereof, having the formula (1):
wherein R is an aryl ring or alkylaryl ring optionally substituted with one or more substituents independently selected from C
1-6
alkyl groups, C
2-6
alkenyl groups, C
2-6
alkynyl groups, C
1-6
alkoxy groups, halogens, nitro groups, aryl groups, C
1-6
acyl groups, carboxylic acids, carboxylic esters, hydroxyl groups, mercapto groups, polycarbo groups, and p-aroyl-L-glutamate;
wherein Z is S, Se, O, NH, CH
2
; and
wherein R
1
is H or a straight, branched or cyclic alkyl group having up to about six carbons optionally substituted with one or more halogen, hydroxyl or amine groups.
The present invention also provides methods of synthesizing compounds having formula (1). Methods for using these compounds in the treatment of various illnesses are also within the scope of the invention.
More specifically, the invention provides a method of using the pyrimidine derivatives of Formula 1 for therapeutic and prophylactic purposes including employing these compounds to resist and treat secondary infections caused by
Pneumocystis carinii, Toxoplasma gondii, Mycobacterium tuberculosis
and
Mycobacterium avium
complex or other organisms in immunocompromised patients. Immunocompromised patients, for example, may be patients with AIDS, or patients undergoing chemotherapy, steroid treatment, and the like; other immunocompromised patients could also be treated according to this invention. In addition, this invention provides methods of using pyrimidine derivatives as antituberculosis, anti
Mycobacterium avium
complex, antibiotic, antimalarial, antifungal and antiprotozoal agents and as synergistic agents with sulfonamides in such patients, although their use in this application may require the use of leucovorin rescue.
This invention also provides methods of using the present pyrimidine derivatives for therapeutic and/or prophylactic purposes as antitumor agents or to otherwise destroy or minimize growth or proliferation of cancerous cells in cancer patients.
It is an aspect of this invention to provide pyrimidine compounds, and pharmaceutically acceptable salts and prodrugs thereof, for substantially inhibiting dihydrofolate reductase enzymes and/or thymidylate synthase enzymes.
It is another aspect of the present invention to provide derivative compounds, and pharmaceutically acceptable salts and prodrugs thereof, having antitumor, antibiotic, antimalarial, antifungal, antiprotozoal, antituberculosis or anti
Mycobacterium avium
activity or synergistic activity with sulfonamides.
It is a further aspect of this invention to provide pyrimidine compounds having activity against secondary infections, such as infections caused by
Pneumocystis carinii, Toxoplasma gondii, Mycobacterium tuberculosis
and
Mycobacterium avium
that occur in immunocompromised patients.
It is another aspect of this invention to provide a method of synthesizing the present pyrimidine compounds and their derivatives.
These and other aspects of the invention will be more fully understood from the drawing and the following description of the invention and the claims appended hereto.


REFERENCES:
patent: 5739141 (1998-04-01), Varney et al.
patent: 6140351 (2000-10-01), Arnaiz et al.
Calas et. al., Eur. J. Med. Chem.—Chim. Ther., (1979), vol. 14(6), pp. 529-537.*
Smal et. al., Chem. Abs., vol. 109, Abs #47847, 1988.

Affiliated with

Also associated with

Rating

Pyrimidine compounds and methods for making and using the same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrimidine compounds and methods for making and using the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine compounds and methods for making and using the same will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2826883